Xponential Fitness (XPOF) Financials

$9.29 +0.55 (+6.29%)

Closing price 05/29/2025 03:59 PM Eastern

Extended Trading

$9.25 -0.04 (-0.47%)

As of 05/29/2025 07:35 PM Eastern

Annual Income Statements for Xponential Fitness

This table shows Xponential Fitness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-68	-4.00	1.22
Consolidated Net Income / (Loss)	-99	-6.44	1.10
Net Income / (Loss) Continuing Operations	-99	-6.44	7.81
Total Pre-Tax Income	-99	-5.41	1.59
Total Operating Income	-54	35	13
Total Gross Profit	239	242	197
Total Revenue	320	318	243
Operating Revenue	320	318	243
Total Cost of Revenue	81	76	46
Operating Cost of Revenue	81	76	46
Total Operating Expenses	293	207	166
Selling, General & Admin Expense	177	169	127
Marketing Expense	27	23	17
Depreciation Expense	18	17	15
Other Operating Expenses / (Income)	8.89	-18	2.44
Impairment Charge	63	17	3.66
Total Other Income / (Expense), net	-45	-40	-23
Interest Expense	46	39	13
Interest & Investment Income	1.82	1.61	1.81
Other Income / (Expense), net	-1.00	-3.19	-12
Income Tax Expense	-0.34	1.03	0.49
Net Income / (Loss) Attributable to Noncontrolling Interest	-31	-2.44	-0.11
Basic Earnings per Share	($2.27)	$1.08	($0.88)
Weighted Average Basic Shares Outstanding	32.00M	31.74M	25.30M
Diluted Earnings per Share	($2.27)	($0.52)	($0.88)
Weighted Average Diluted Shares Outstanding	32.00M	39.71M	25.30M
Weighted Average Basic & Diluted Shares Outstanding	48.48M	47.49M	49.27M

This table shows Xponential Fitness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-44	-12	-9.10	-2.87	-9.02	-3.38	18	-9.98	-0.96	-7.14
Consolidated Net Income / (Loss)	-63	-18	-14	-4.36	-14	-5.18	28	-15	-2.14	-13
Net Income / (Loss) Continuing Operations	-63	-18	-14	-4.36	-14	-5.18	28	-15	4.57	-13
Total Pre-Tax Income	-63	-18	-14	-4.40	-13	-4.98	28	-15	-1.50	-13
Total Operating Income	-52	-6.43	-2.41	7.39	-1.82	7.48	36	-7.21	-18	10
Total Gross Profit	63	59	58	60	65	64	59	53	72	47
Total Revenue	84	80	77	80	89	80	77	71	70	64
Operating Revenue	84	80	77	80	89	80	77	71	70	64
Total Cost of Revenue	21	22	19	20	24	16	18	18	-2.09	17
Operating Cost of Revenue	21	22	19	20	24	16	18	18	-2.09	17
Total Operating Expenses	115	65	60	53	67	57	23	60	51	58
Selling, General & Admin Expense	57	46	37	37	53	44	37	35	31	33
Marketing Expense	5.89	6.42	7.85	6.52	6.39	5.82	5.47	5.01	4.59	4.26
Depreciation Expense	4.53	4.23	4.52	4.44	4.18	4.22	4.29	4.20	4.09	4.15
Other Operating Expenses / (Income)	1.92	3.66	-1.22	4.52	-1.03	-1.92	-31	16	8.23	16
Total Other Income / (Expense), net	-11	-11	-11	-12	-11	-12	-8.80	-7.90	-15	-2.93
Interest Expense	12	12	11	12	11	11	8.63	7.98	3.96	3.33
Interest & Investment Income	0.59	0.48	0.39	0.36	0.42	0.02	0.53	0.64	0.60	0.40
Other Income / (Expense), net	-0.09	-0.05	-0.25	-0.61	-0.10	-1.85	-0.70	-0.55	-	-
Income Tax Expense	-0.56	0.13	0.13	-0.05	0.82	0.20	0.13	-0.12	0.65	-0.31
Net Income / (Loss) Attributable to Noncontrolling Interest	-19	-5.97	-4.56	-1.49	-4.79	-1.80	9.15	-5.00	-1.18	-5.92
Basic Earnings per Share	($1.39)	($0.29)	($0.29)	($0.30)	$0.11	$0.91	$1.44	($1.38)	($1.12)	($1.53)
Weighted Average Basic Shares Outstanding	32.00M	32.18M	31.81M	31.13M	31.74M	32.26M	33.05M	30.75M	25.30M	26.16M
Diluted Earnings per Share	($1.39)	($0.29)	($0.29)	($0.30)	$1.27	($0.50)	$0.09	($1.38)	$1.66	($1.53)
Weighted Average Diluted Shares Outstanding	32.00M	32.18M	31.81M	31.13M	39.71M	40.22M	41.59M	30.75M	25.30M	26.16M
Weighted Average Basic & Diluted Shares Outstanding	48.48M	48.30M	48.18M	48.07M	47.49M	47.46M	49.97M	49.56M	49.27M	49.22M

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-4.36	-0.28	16
Net Cash From Operating Activities	12	33	52
Net Cash From Continuing Operating Activities	12	33	52
Net Income / (Loss) Continuing Operations	-99	-6.44	1.10
Consolidated Net Income / (Loss)	-99	-6.44	1.10
Depreciation Expense	18	17	15
Amortization Expense	4.36	3.41	0.74
Non-Cash Adjustments To Reconcile Net Income	74	47	33
Changes in Operating Assets and Liabilities, net	14	-28	1.41
Net Cash From Investing Activities	-14	-12	-15
Net Cash From Continuing Investing Activities	-14	-12	-15
Purchase of Property, Plant & Equipment	-4.71	-7.43	-8.96
Acquisitions	-10	-4.35	-7.18
Sale of Property, Plant & Equipment	0.88	0.84	3.30
Other Investing Activities, net	0.00	-0.75	-1.78
Net Cash From Financing Activities	-1.88	-21	-21
Net Cash From Continuing Financing Activities	-1.88	-21	-21
Repayment of Debt	-44	-4.61	-3.03
Repurchase of Preferred Equity	0.00	-131	0.00
Repurchase of Common Equity	0.00	-50	0.00
Payment of Dividends	-15	-19	-17
Issuance of Debt	63	189	7.43
Issuance of Preferred Equity	0.00	0.00	0.00
Issuance of Common Equity	0.21	0.00	0.00
Other Financing Activities, net	-6.16	-5.36	-9.15
Cash Interest Paid	41	35	12
Cash Income Taxes Paid	0.56	1.57	2.79

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-5.04	12	-1.20	-9.88	-15	12	12	-9.24	6.48	1.63
Net Cash From Operating Activities	0.76	5.22	3.00	2.70	-5.48	7.63	19	11	15	11
Net Cash From Continuing Operating Activities	0.76	5.22	3.00	2.70	-5.48	7.63	19	11	15	11
Net Income / (Loss) Continuing Operations	-63	-18	-14	-4.36	-14	-5.18	28	-15	-2.14	-13
Consolidated Net Income / (Loss)	-63	-18	-14	-4.36	-14	-5.18	28	-15	-2.14	-13
Depreciation Expense	4.53	4.23	4.52	4.44	4.18	4.22	4.29	4.20	4.09	4.15
Amortization Expense	1.05	0.98	0.93	1.40	0.96	0.93	0.62	0.89	-1.26	0.75
Non-Cash Adjustments To Reconcile Net Income	46	9.78	15	2.92	11	14	16	6.77	7.22	7.89
Changes in Operating Assets and Liabilities, net	12	8.20	-4.19	-1.70	-7.54	-5.88	-29	14	6.69	12
Net Cash From Investing Activities	-0.22	-2.17	-2.56	-9.20	-3.09	-2.98	-3.23	-2.39	-3.04	-5.94
Net Cash From Continuing Investing Activities	-0.22	-2.17	-2.56	-9.20	-3.09	-2.98	-3.23	-2.39	-3.04	-5.94
Purchase of Property, Plant & Equipment	0.10	-1.83	-2.13	-0.86	-1.27	-1.80	-2.23	-2.13	-3.30	-1.27
Acquisitions	-0.38	-0.42	-0.51	-9.01	-1.93	-0.99	-0.96	-0.47	-0.34	-5.93
Sale of Property, Plant & Equipment	0.06	0.08	0.08	0.66	0.11	0.35	0.16	0.21	0.59	1.67
Net Cash From Financing Activities	-5.58	8.71	-1.65	-3.37	-6.21	7.04	-3.93	-18	-5.08	-3.71
Net Cash From Continuing Financing Activities	-5.58	8.71	-1.65	-3.37	-6.21	7.04	-3.93	-18	-5.08	-3.71
Repayment of Debt	-1.35	-1.40	-1.29	-40	-1.19	-1.49	-0.76	-1.18	-0.76	-0.74
Payment of Dividends	-3.94	-8.54	-0.30	-1.91	-6.17	-10	-1.82	-1.32	-3.64	-3.25
Issuance of Common Equity	0.14	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-0.43	-5.60	-0.14	0.00	1.15	5.88	-1.35	-11	-2.62	-5.20
Cash Interest Paid	10	11	10	9.86	10	9.67	7.92	7.04	3.62	2.99
Cash Income Taxes Paid	-0.02	0.18	0.35	0.06	-0.11	0.57	0.55	0.55	0.22	0.57

This table presents Xponential Fitness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	403	530	483
Total Current Assets	84	97	86
Cash & Equivalents	33	37	37
Note & Lease Receivable	0.23	0.20	1.52
Accounts Receivable	32	32	26
Inventories, net	10	16	11
Prepaid Expenses	4.87	5.59	6.29
Other Current Assets	4.60	6.89	4.13
Plant, Property, & Equipment, net	15	20	19
Total Noncurrent Assets	305	413	378
Noncurrent Note & Lease Receivables	0.10	0.80	1.07
Goodwill	135	171	166
Intangible Assets	101	120	137
Other Noncurrent Operating Assets	68	121	74
Total Liabilities & Shareholders' Equity	403	530	483
Total Liabilities	597	624	383
Total Current Liabilities	108	102	73
Short-Term Debt	5.40	4.76	3.04
Accounts Payable	27	19	16
Accrued Expenses	31	20	12
Current Deferred Revenue	26	35	32
Other Current Liabilities	18	24	9.27
Total Noncurrent Liabilities	490	522	310
Long-Term Debt	342	319	133
Noncurrent Deferred Revenue	106	117	109
Other Noncurrent Operating Liabilities	42	86	67
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	117	115	308
Total Equity & Noncontrolling Interests	-311	-210	-208
Total Preferred & Common Equity	-217	-130	-155
Preferred Stock	0.00	0.00	0.00
Total Common Equity	-217	-130	-155
Common Stock	504	521	505
Retained Earnings	-702	-634	-642
Treasury Stock	-1.70	-1.70	-1.70
Other Equity Adjustments	-17	-15	-16
Noncontrolling Interest	-94	-80	-53

This table presents Xponential Fitness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	472	475	508	551	545	484	472
Total Current Assets	96	86	88	117	97	79	80
Cash & Equivalents	38	26	27	52	40	28	31
Note & Lease Receivable	0.28	0.35	0.07	1.11	1.50	1.50	1.93
Accounts Receivable	30	30	32	28	27	22	19
Inventories, net	11	13	15	16	12	13	14
Prepaid Expenses	8.34	8.24	5.66	14	12	9.92	11
Other Current Assets	9.02	8.07	7.33	6.51	4.26	4.08	3.57
Plant, Property, & Equipment, net	19	19	19	20	21	19	17
Total Noncurrent Assets	358	371	401	414	427	386	375
Noncurrent Note & Lease Receivables	0.10	0.11	0.65	1.18	0.64	0.85	3.11
Goodwill	163	163	174	166	171	166	166
Intangible Assets	118	120	124	122	125	135	140
Other Noncurrent Operating Assets	77	88	103	125	131	85	67
Total Liabilities & Shareholders' Equity	472	475	508	551	545	484	472
Total Liabilities	596	576	600	628	568	536	396
Total Current Liabilities	94	92	92	102	100	77	81
Short-Term Debt	5.40	5.15	5.15	5.20	4.26	4.26	3.04
Accounts Payable	21	23	25	24	27	19	23
Accrued Expenses	21	14	13	13	15	14	19
Current Deferred Revenue	29	29	30	37	35	31	29
Other Current Liabilities	17	20	19	22	20	8.55	6.62
Total Noncurrent Liabilities	501	484	508	527	467	459	315
Long-Term Debt	342	318	319	319	257	258	132
Noncurrent Deferred Revenue	109	111	116	115	113	111	108
Other Noncurrent Operating Liabilities	51	54	73	92	97	90	75
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	117	123	123	130	182	227	257
Total Equity & Noncontrolling Interests	-240	-224	-214	-207	-204	-279	-181
Total Preferred & Common Equity	-156	-152	-144	-138	-158	-223	-127
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-156	-152	-144	-138	-158	-223	-127
Common Stock	517	508	506	503	486	438	529
Retained Earnings	-654	-642	-633	-624	-621	-639	-642
Treasury Stock	-1.70	-1.70	-1.70	-1.70	-1.70	-1.70	-
Other Equity Adjustments	-17	-16	-16	-15	-22	-20	-14
Noncontrolling Interest	-84	-72	-70	-69	-46	-56	-54

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	0.76%	30.73%	56.82%
EBITDA Growth	-162.57%	194.78%	244.69%
EBIT Growth	-272.21%	1,895.78%	105.16%
NOPAT Growth	-253.60%	164.67%	142.79%
Net Income Growth	-1,431.83%	-685.20%	102.14%
EPS Growth	-336.54%	40.91%	69.12%
Operating Cash Flow Growth	-64.30%	-37.17%	260.28%
Free Cash Flow Firm Growth	9.76%	349.61%	44.34%
Invested Capital Growth	-37.31%	-3.35%	12.25%
Revenue Q/Q Growth	-1.95%	6.07%	9.03%
EBITDA Q/Q Growth	-192.62%	27.80%	-18.39%
EBIT Q/Q Growth	-11,155.06%	58.10%	-67.47%
NOPAT Q/Q Growth	-3,667.13%	37.41%	170.04%
Net Income Q/Q Growth	-119.02%	-192.11%	104.15%
EPS Q/Q Growth	-582.98%	-333.33%	82.44%
Operating Cash Flow Q/Q Growth	43.40%	-37.56%	8.47%
Free Cash Flow Firm Q/Q Growth	237.82%	1,066.24%	0.00%
Invested Capital Q/Q Growth	-35.38%	-1.70%	10.24%
Profitability Metrics	-	-	-
Gross Margin	74.63%	76.00%	80.90%
EBITDA Margin	-10.16%	16.36%	7.25%
Operating Margin	-16.74%	10.98%	5.48%
EBIT Margin	-17.05%	9.97%	0.65%
Profit (Net Income) Margin	-30.81%	-2.03%	0.45%
Tax Burden Percent	99.65%	119.12%	69.29%
Interest Burden Percent	181.35%	-17.06%	100.00%
Effective Tax Rate	0.00%	0.00%	30.71%
Return on Invested Capital (ROIC)	-24.02%	12.51%	4.91%
ROIC Less NNEP Spread (ROIC-NNEP)	-44.37%	-3.51%	-2.86%
Return on Net Nonoperating Assets (RNNOA)	92.35%	-263.16%	-3.59%
Return on Equity (ROE)	68.33%	-250.65%	1.32%
Cash Return on Invested Capital (CROIC)	21.85%	15.92%	-6.63%
Operating Return on Assets (OROA)	-11.71%	6.27%	0.35%
Return on Assets (ROA)	-21.16%	-1.27%	0.25%
Return on Common Equity (ROCE)	81.98%	13,884.67%	-6.43%
Return on Equity Simple (ROE_SIMPLE)	45.57%	4.96%	-0.71%
Net Operating Profit after Tax (NOPAT)	-38	24	9.23
NOPAT Margin	-11.72%	7.69%	3.80%
Net Nonoperating Expense Percent (NNEP)	20.34%	16.01%	7.77%
Return On Investment Capital (ROIC_SIMPLE)	-103.32%	21.34%	-12.82%
Cost of Revenue to Revenue	25.37%	24.00%	19.10%
SG&A Expenses to Revenue	55.21%	53.11%	52.14%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	91.36%	65.02%	68.05%
Earnings before Interest and Taxes (EBIT)	-55	32	1.59
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-33	52	18
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	1.92	4.64
Price to Earnings (P/E)	0.00	0.00	928.88
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.11%
Enterprise Value to Invested Capital (EV/IC)	0.00	4.86	7.46
Enterprise Value to Revenue (EV/Rev)	0.00	2.94	6.09
Enterprise Value to EBITDA (EV/EBITDA)	0.00	17.95	84.00
Enterprise Value to EBIT (EV/EBIT)	0.00	29.44	932.71
Enterprise Value to NOPAT (EV/NOPAT)	0.00	38.22	160.54
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	28.54	28.47
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	30.03	0.00
Leverage & Solvency	-	-	-
Debt to Equity	-1.79	-3.42	1.36
Long-Term Debt to Equity	-1.76	-3.37	1.33
Financial Leverage	-2.08	75.01	1.26
Leverage Ratio	-3.23	196.89	5.40
Compound Leverage Factor	-5.86	-33.58	5.40
Debt to Total Capital	226.69%	141.40%	57.64%
Short-Term Debt to Total Capital	3.52%	2.08%	1.29%
Long-Term Debt to Total Capital	223.17%	139.32%	56.35%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	14.74%	15.33%	107.92%
Common Equity to Total Capital	-141.43%	-56.73%	-65.56%
Debt to EBITDA	-10.67	6.23	7.71
Net Debt to EBITDA	-9.66	5.52	5.59
Long-Term Debt to EBITDA	-10.50	6.14	7.54
Debt to NOPAT	-9.25	13.26	14.74
Net Debt to NOPAT	-8.38	11.74	10.69
Long-Term Debt to NOPAT	-9.11	13.07	14.41
Altman Z-Score	0.00	-0.30	0.45
Noncontrolling Interest Sharing Ratio	-19.97%	5,639.43%	586.20%
Liquidity Ratios	-	-	-
Current Ratio	0.78	0.95	1.18
Quick Ratio	0.60	0.67	0.89
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	34	31	-12
Operating Cash Flow to CapEx	304.56%	496.10%	920.83%
Free Cash Flow to Firm to Interest Expense	0.74	0.80	-0.96
Operating Cash Flow to Interest Expense	0.25	0.84	4.00
Operating Cash Flow Less CapEx to Interest Expense	0.17	0.67	3.57
Efficiency Ratios	-	-	-
Asset Turnover	0.69	0.63	0.54
Accounts Receivable Turnover	10.12	11.12	13.06
Inventory Turnover	6.35	5.77	5.22
Fixed Asset Turnover	18.76	16.72	15.54
Accounts Payable Turnover	3.56	4.39	2.99
Days Sales Outstanding (DSO)	36.06	32.81	27.96
Days Inventory Outstanding (DIO)	57.49	63.26	69.90
Days Payable Outstanding (DPO)	102.45	83.23	122.15
Cash Conversion Cycle (CCC)	-8.90	12.84	-24.29
Capital & Investment Metrics	-	-	-
Invested Capital	120	192	199
Invested Capital Turnover	2.05	1.63	1.29
Increase / (Decrease) in Invested Capital	-72	-6.66	22
Enterprise Value (EV)	0.00	934	1,482
Market Capitalization	0.00	612	1,129
Book Value per Share	($6.77)	($2.74)	($3.14)
Tangible Book Value per Share	($14.15)	($8.87)	($9.30)
Total Capital	153	229	236
Total Debt	347	324	136
Total Long-Term Debt	342	319	133
Net Debt	314	287	99
Capital Expenditures (CapEx)	3.83	6.59	5.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-51	-38	-21
Debt-free Net Working Capital (DFNWC)	-18	-0.49	16
Net Working Capital (NWC)	-24	-5.25	13
Net Nonoperating Expense (NNE)	61	31	8.13
Net Nonoperating Obligations (NNO)	314	287	99
Total Depreciation and Amortization (D&A)	22	20	16
Debt-free, Cash-free Net Working Capital to Revenue	-15.95%	-11.82%	-8.79%
Debt-free Net Working Capital to Revenue	-5.73%	-0.16%	6.58%
Net Working Capital to Revenue	-7.41%	-1.65%	5.33%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.27)	$1.18	($0.87)
Adjusted Weighted Average Basic Shares Outstanding	32.00M	31.74M	25.30M
Adjusted Diluted Earnings per Share	($2.27)	($0.44)	($0.87)
Adjusted Weighted Average Diluted Shares Outstanding	32.00M	39.71M	25.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.48M	47.49M	49.27M
Normalized Net Operating Profit after Tax (NOPAT)	6.26	36	12
Normalized NOPAT Margin	1.95%	11.37%	4.84%
Pre Tax Income Margin	-30.92%	-1.70%	0.65%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-1.18	0.82	0.12
NOPAT to Interest Expense	-0.81	0.63	0.71
EBIT Less CapEx to Interest Expense	-1.26	0.65	-0.31
NOPAT Less CapEx to Interest Expense	-0.89	0.46	0.27
Payout Ratios	-	-	-
Dividend Payout Ratio	-14.88%	-300.06%	1,511.72%
Augmented Payout Ratio	-14.88%	-1,081.96%	1,511.72%

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.32%	0.07%	-1.06%	12.49%	28.71%	26.15%	29.85%	40.36%	40.80%	56.03%
EBITDA Growth	-1,543.90%	-111.76%	-93.15%	572.01%	120.66%	-29.67%	0.85%	74.86%	33.15%	780.64%
EBIT Growth	-2,630.04%	-214.98%	-107.44%	187.35%	89.64%	-46.01%	-1.07%	47.47%	31.36%	417.21%
NOPAT Growth	-2,769.53%	-185.93%	-104.65%	202.51%	90.16%	-28.32%	7.45%	51.22%	31.36%	417.21%
Net Income Growth	-354.24%	-246.71%	-149.64%	70.92%	-544.79%	60.30%	-12.56%	1.32%	92.81%	-46.63%
EPS Growth	-209.45%	42.00%	-422.22%	78.26%	-23.49%	67.32%	-82.00%	8.61%	167.21%	-302.63%
Operating Cash Flow Growth	113.90%	-31.59%	-84.38%	-76.26%	-137.56%	-32.35%	-17.56%	293.04%	38.64%	230.22%
Free Cash Flow Firm Growth	552.07%	146.08%	-99.04%	-75.77%	115.57%	-4.90%	8.07%	94.60%	0.00%	94.32%
Invested Capital Growth	-37.31%	-4.63%	-1.00%	12.60%	-3.35%	8.39%	1.87%	2.87%	12.25%	10.23%
Revenue Q/Q Growth	4.13%	5.19%	-3.78%	-11.83%	11.24%	4.00%	9.41%	-0.81%	9.02%	7.06%
EBITDA Q/Q Growth	-3,580.36%	-145.55%	-77.93%	11.86%	-70.03%	-73.48%	1,621.89%	76.10%	-202.05%	-61.98%
EBIT Q/Q Growth	-706.75%	-143.40%	-139.25%	137.61%	-133.98%	-84.25%	560.70%	53.43%	-277.10%	-71.13%
NOPAT Q/Q Growth	-711.83%	-166.86%	-132.59%	150.53%	-124.31%	-85.57%	819.10%	-126.15%	-277.10%	-78.37%
Net Income Q/Q Growth	-248.96%	-31.53%	-213.64%	52.00%	-166.35%	-118.83%	283.75%	-3,981.47%	83.60%	-141.48%
EPS Q/Q Growth	-379.31%	0.00%	3.33%	-122.22%	354.00%	-655.56%	106.52%	-182.63%	208.50%	-406.00%
Operating Cash Flow Q/Q Growth	-85.40%	73.91%	11.35%	197.22%	-171.84%	-60.29%	69.27%	-20.06%	29.41%	-51.61%
Free Cash Flow Firm Q/Q Growth	671.89%	1,357.36%	101.76%	-994.96%	154.55%	-130.29%	422.20%	-322.45%	-267.60%	-131.20%
Invested Capital Q/Q Growth	-35.38%	-5.34%	-4.11%	3.25%	-1.70%	-1.74%	9.07%	-8.27%	10.24%	-7.64%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	74.79%	72.74%	75.56%	75.46%	73.13%	79.78%	76.81%	74.44%	103.01%	73.89%
EBITDA Margin	-55.68%	-1.58%	3.64%	15.86%	3.61%	13.41%	52.58%	-3.78%	-22.51%	24.05%
Operating Margin	-62.24%	-7.98%	-3.15%	9.29%	-2.03%	9.30%	47.13%	-10.20%	-26.58%	16.36%
EBIT Margin	-62.34%	-8.05%	-3.48%	8.52%	-2.14%	7.00%	46.23%	-10.98%	-26.58%	16.36%
Profit (Net Income) Margin	-74.82%	-22.33%	-17.85%	-5.48%	-15.43%	-6.44%	35.59%	-21.19%	-3.08%	-20.48%
Tax Burden Percent	99.12%	100.73%	100.98%	98.93%	106.33%	104.06%	99.52%	99.19%	143.21%	97.70%
Interest Burden Percent	121.08%	275.42%	508.46%	-64.95%	678.32%	-88.43%	77.35%	194.59%	8.09%	-128.09%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.48%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-89.34%	-9.57%	-3.64%	10.99%	-2.31%	10.39%	67.40%	-10.53%	-24.09%	14.86%
ROIC Less NNEP Spread (ROIC-NNEP)	-98.05%	-14.20%	-8.25%	7.40%	-8.81%	4.85%	61.96%	-16.24%	-13.77%	-8.65%
Return on Net Nonoperating Assets (RNNOA)	204.10%	41.25%	34.69%	-27.46%	-661.16%	-3,382.81%	277.49%	-506.88%	-17.32%	-8.78%
Return on Equity (ROE)	114.76%	31.68%	31.05%	-16.47%	-663.47%	-3,372.42%	344.89%	-517.41%	-41.41%	6.08%
Cash Return on Invested Capital (CROIC)	21.85%	5.29%	6.46%	12.96%	15.92%	1.42%	6.32%	4.18%	-6.63%	0.00%
Operating Return on Assets (OROA)	-42.81%	-5.14%	-2.23%	5.62%	-1.34%	4.10%	25.95%	-6.34%	-14.39%	8.74%
Return on Assets (ROA)	-51.38%	-14.25%	-11.43%	-3.61%	-9.69%	-3.77%	19.98%	-12.23%	-1.67%	-10.94%
Return on Common Equity (ROCE)	137.68%	46.50%	78.06%	-42.31%	36,752.58%	-1,660,464.63%	-1,040.78%	19,440.70%	201.32%	-18.70%
Return on Equity Simple (ROE_SIMPLE)	0.00%	28.94%	21.24%	-6.17%	0.00%	-5.06%	0.55%	-1.38%	0.00%	20.89%
Net Operating Profit after Tax (NOPAT)	-37	-4.50	-1.69	5.17	-1.27	5.23	36	-5.04	-13	7.30
NOPAT Margin	-43.57%	-5.59%	-2.20%	6.50%	-1.42%	6.51%	46.91%	-7.14%	-18.61%	11.45%
Net Nonoperating Expense Percent (NNEP)	8.71%	4.63%	4.61%	3.59%	6.50%	5.54%	5.44%	5.70%	-10.31%	23.51%
Return On Investment Capital (ROIC_SIMPLE)	-100.53%	-	-	-	-1.11%	-	-	-	17.97%	-
Cost of Revenue to Revenue	25.21%	27.26%	24.44%	24.54%	26.87%	20.23%	23.19%	25.56%	-3.01%	26.11%
SG&A Expenses to Revenue	67.46%	57.35%	48.34%	46.72%	59.08%	54.59%	48.11%	49.35%	44.19%	51.50%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	137.03%	80.73%	78.71%	66.17%	75.16%	70.48%	29.67%	84.64%	73.78%	90.25%
Earnings before Interest and Taxes (EBIT)	-52	-6.48	-2.66	6.78	-1.91	5.63	36	-7.76	-18	10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-47	-1.27	2.78	13	3.23	11	41	-2.67	-16	15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	1.83	2.30	2.40	1.92	2.58	3.02	5.64	4.64	4.00
Price to Earnings (P/E)	0.00	0.00	0.00	126.42	0.00	162.47	845.56	0.00	928.88	5,760.62
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.79%	0.00%	0.62%	0.12%	0.00%	0.11%	0.02%
Enterprise Value to Invested Capital (EV/IC)	0.00	5.04	5.58	5.53	4.86	5.67	6.10	10.44	7.46	6.66
Enterprise Value to Revenue (EV/Rev)	0.00	2.88	3.36	3.47	2.94	3.70	4.28	7.17	6.09	5.38
Enterprise Value to EBITDA (EV/EBITDA)	0.00	26.74	23.29	13.34	17.95	27.23	27.93	44.92	84.00	55.52
Enterprise Value to EBIT (EV/EBIT)	0.00	1,901.64	87.17	22.25	29.44	55.25	52.67	83.80	932.71	245.75
Enterprise Value to NOPAT (EV/NOPAT)	0.00	892.89	101.87	23.61	38.22	62.32	75.24	151.11	160.54	351.06
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	115.36	104.11	42.41	28.54	21.15	21.63	31.64	28.47	25.01
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	92.98	85.95	45.20	30.03	415.61	97.35	253.29	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.79	-2.82	-3.21	-3.54	-3.42	-4.21	-11.51	-5.09	1.36	1.76
Long-Term Debt to Equity	-1.76	-2.77	-3.16	-3.48	-3.37	-4.14	-11.33	-5.01	1.33	1.72
Financial Leverage	-2.08	-2.91	-4.20	-3.71	75.01	-697.91	4.48	31.22	1.26	1.02
Leverage Ratio	-3.23	-5.11	-8.26	-6.94	196.89	-1,898.89	14.02	82.36	5.40	4.90
Compound Leverage Factor	-3.91	-14.07	-42.01	4.51	1,335.56	1,679.10	10.85	160.26	0.44	-6.27
Debt to Total Capital	226.69%	155.04%	145.21%	139.35%	141.40%	131.14%	109.51%	124.46%	57.64%	63.79%
Short-Term Debt to Total Capital	3.52%	2.41%	2.31%	2.21%	2.08%	2.10%	1.78%	2.02%	1.29%	1.44%
Long-Term Debt to Total Capital	223.17%	152.63%	142.90%	137.14%	139.32%	129.04%	107.73%	122.43%	56.35%	62.36%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	14.74%	14.45%	22.97%	22.78%	15.33%	24.80%	56.80%	81.43%	107.92%	96.38%
Common Equity to Total Capital	-141.43%	-69.48%	-68.18%	-62.13%	-56.73%	-55.94%	-66.31%	-105.89%	-65.56%	-60.17%
Debt to EBITDA	-10.67	9.89	6.86	3.81	6.23	7.97	6.03	6.18	7.71	6.23
Net Debt to EBITDA	-9.66	8.81	6.31	3.49	5.52	6.69	5.11	5.52	5.59	4.80
Long-Term Debt to EBITDA	-10.50	9.74	6.75	3.75	6.14	7.84	5.93	6.08	7.54	6.09
Debt to NOPAT	-9.25	330.23	30.01	6.74	13.26	18.24	16.25	20.80	14.74	39.40
Net Debt to NOPAT	-8.38	294.33	27.59	6.17	11.74	15.32	13.75	18.57	10.69	30.36
Long-Term Debt to NOPAT	-9.11	325.10	29.53	6.63	13.07	17.94	15.98	20.46	14.41	38.51
Altman Z-Score	0.00	-0.69	-0.46	-0.28	-0.51	-0.23	0.04	0.33	0.32	0.00
Noncontrolling Interest Sharing Ratio	-19.97%	-46.78%	-151.38%	-156.92%	5,639.43%	-49,136.55%	401.77%	3,857.30%	586.20%	407.34%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.78	1.02	0.93	0.95	0.95	1.15	0.96	1.02	1.18	0.99
Quick Ratio	0.60	0.72	0.61	0.64	0.67	0.80	0.68	0.67	0.89	0.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	35	4.55	0.31	-18	5.39	-9.88	33	-10	-35	-9.42
Operating Cash Flow to CapEx	0.00%	297.55%	146.39%	1,382.05%	-470.88%	528.69%	927.32%	592.74%	540.08%	0.00%
Free Cash Flow to Firm to Interest Expense	3.03	0.38	0.03	-1.54	0.47	-0.93	3.78	-1.27	-8.75	-2.83
Operating Cash Flow to Interest Expense	0.07	0.44	0.27	0.23	-0.48	0.72	2.23	1.42	3.69	3.38
Operating Cash Flow Less CapEx to Interest Expense	0.08	0.29	0.08	0.22	-0.58	0.58	1.99	1.18	3.01	3.51
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.64	0.64	0.66	0.63	0.59	0.56	0.58	0.54	0.53
Accounts Receivable Turnover	10.12	11.41	11.51	11.99	11.12	12.73	12.12	13.86	13.06	16.91
Inventory Turnover	6.35	6.07	6.04	5.34	5.77	4.61	5.32	6.30	5.22	6.58
Fixed Asset Turnover	18.76	16.70	16.45	16.97	16.72	16.24	15.55	16.04	15.54	15.39
Accounts Payable Turnover	3.56	3.60	3.08	3.45	4.39	2.93	2.41	4.50	2.99	3.24
Days Sales Outstanding (DSO)	36.06	31.99	31.73	30.45	32.81	28.67	30.11	26.33	27.96	21.58
Days Inventory Outstanding (DIO)	57.49	60.14	60.48	68.39	63.26	79.09	68.60	57.90	69.90	55.47
Days Payable Outstanding (DPO)	102.45	101.32	118.68	105.95	83.23	124.75	151.18	81.19	122.15	112.63
Cash Conversion Cycle (CCC)	-8.90	-9.18	-26.48	-7.10	12.84	-16.98	-52.47	3.04	-24.29	-35.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	120	186	197	205	192	195	199	182	199	180
Invested Capital Turnover	2.05	1.71	1.65	1.69	1.63	1.60	1.44	1.48	1.29	1.30
Increase / (Decrease) in Invested Capital	-72	-9.05	-2.00	23	-6.66	15	3.66	5.08	22	17
Enterprise Value (EV)	0.00	939	1,099	1,135	934	1,108	1,212	1,902	1,482	1,200
Market Capitalization	0.00	597	750	785	612	774	855	1,497	1,129	893
Book Value per Share	($6.77)	($3.23)	($3.16)	($3.04)	($2.74)	($2.77)	($3.20)	($4.52)	($3.14)	($2.60)
Tangible Book Value per Share	($14.15)	($9.06)	($9.05)	($9.32)	($8.87)	($8.53)	($9.16)	($10.62)	($9.30)	($8.84)
Total Capital	153	224	223	232	229	247	239	210	236	211
Total Debt	347	347	324	324	324	324	262	262	136	135
Total Long-Term Debt	342	342	318	319	319	319	257	258	133	132
Net Debt	314	310	298	297	287	272	222	234	99	104
Capital Expenditures (CapEx)	-0.17	1.75	2.05	0.20	1.16	1.44	2.07	1.92	2.70	-0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-51	-31	-27	-27	-38	-31	-40	-22	-21	-28
Debt-free Net Working Capital (DFNWC)	-18	6.83	-0.96	0.54	-0.49	21	0.40	6.11	16	2.49
Net Working Capital (NWC)	-24	1.43	-6.11	-4.61	-5.25	16	-3.86	1.85	13	-0.54
Net Nonoperating Expense (NNE)	26	13	12	9.53	13	10	8.75	9.93	-11	20
Net Nonoperating Obligations (NNO)	314	310	298	297	287	272	222	234	99	104
Total Depreciation and Amortization (D&A)	5.59	5.21	5.45	5.83	5.15	5.15	4.91	5.09	2.83	4.90
Debt-free, Cash-free Net Working Capital to Revenue	-15.95%	-9.47%	-8.26%	-8.15%	-11.82%	-10.38%	-14.06%	-8.30%	-8.79%	-12.73%
Debt-free Net Working Capital to Revenue	-5.73%	2.09%	-0.29%	0.16%	-0.16%	6.93%	0.14%	2.30%	6.58%	1.12%
Net Working Capital to Revenue	-7.41%	0.44%	-1.87%	-1.41%	-1.65%	5.19%	-1.36%	0.70%	5.33%	-0.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.39)	($0.29)	($0.29)	($0.30)	$0.11	$0.91	$1.44	($1.38)	($1.12)	($1.53)
Adjusted Weighted Average Basic Shares Outstanding	32.00M	32.18M	31.81M	31.13M	31.74M	32.26M	33.05M	30.75M	25.30M	26.16M
Adjusted Diluted Earnings per Share	($1.39)	($0.29)	($0.29)	($0.30)	$1.27	($0.50)	$0.09	($1.38)	$1.66	($1.53)
Adjusted Weighted Average Diluted Shares Outstanding	32.00M	32.18M	31.81M	31.13M	39.71M	40.22M	41.59M	30.75M	25.30M	26.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.48M	48.30M	48.18M	48.07M	47.49M	47.46M	49.97M	49.56M	49.27M	49.22M
Normalized Net Operating Profit after Tax (NOPAT)	-37	-1.35	6.78	5.17	-1.27	8.50	43	-5.04	-13	7.30
Normalized NOPAT Margin	-43.57%	-1.67%	8.86%	6.50%	-1.42%	10.57%	56.22%	-7.14%	-18.61%	11.45%
Pre Tax Income Margin	-75.48%	-22.16%	-17.68%	-5.54%	-14.51%	-6.19%	35.76%	-21.36%	-2.15%	-20.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.50	-0.55	-0.24	0.59	-0.17	0.53	4.14	-0.97	-4.67	3.13
NOPAT to Interest Expense	-3.15	-0.38	-0.15	0.45	-0.11	0.49	4.21	-0.63	-3.27	2.19
EBIT Less CapEx to Interest Expense	-4.49	-0.70	-0.42	0.57	-0.27	0.39	3.90	-1.21	-5.35	3.25
NOPAT Less CapEx to Interest Expense	-3.13	-0.53	-0.33	0.43	-0.21	0.36	3.97	-0.87	-3.95	2.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-14.88%	-39.01%	-59.03%	230.99%	-300.06%	234.62%	-1,098.41%	412.85%	1,511.72%	-67.34%
Augmented Payout Ratio	-14.88%	-39.01%	-59.03%	230.99%	-1,081.96%	954.82%	-1,098.41%	412.85%	1,511.72%	-66.82%

Frequently Asked Questions About Xponential Fitness' Financials

When does Xponential Fitness's financial year end?

According to the most recent income statement we have on file, Xponential Fitness' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xponential Fitness' net income changed over the last 2 years?

Xponential Fitness' net income appears to be on an upward trend, with a most recent value of -$98.70 million in 2024, falling from $1.10 million in 2022. The previous period was -$6.44 million in 2023. View Xponential Fitness' forecast to see where analysts expect Xponential Fitness to go next.

What is Xponential Fitness's operating income?

Xponential Fitness's total operating income in 2024 was -$53.61 million, based on the following breakdown:

Total Gross Profit: $239.06 million
Total Operating Expenses: $292.68 million

How has Xponential Fitness revenue changed over the last 2 years?

Over the last 2 years, Xponential Fitness' total revenue changed from $243.20 million in 2022 to $320.35 million in 2024, a change of 31.7%.

How much debt does Xponential Fitness have?

Xponential Fitness' total liabilities were at $597.40 million at the end of 2024, a 4.3% decrease from 2023, and a 56.1% increase since 2022.

How much cash does Xponential Fitness have?

In the past 2 years, Xponential Fitness' cash and equivalents has ranged from $32.74 million in 2024 to $37.37 million in 2022, and is currently $32.74 million as of their latest financial filing in 2024.

How has Xponential Fitness' book value per share changed over the last 2 years?

Over the last 2 years, Xponential Fitness' book value per share changed from -3.14 in 2022 to -6.77 in 2024, a change of 115.2%.

Related Companies

This page (NYSE:XPOF) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xponential Fitness (XPOF) Financials

Frequently Asked Questions About Xponential Fitness' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xponential Fitness (XPOF) Financials

Annual Income Statements for Xponential Fitness

Quarterly Income Statements for Xponential Fitness

Annual Cash Flow Statements for Xponential Fitness

Quarterly Cash Flow Statements for Xponential Fitness

Annual Balance Sheets for Xponential Fitness

Quarterly Balance Sheets for Xponential Fitness

Annual Metrics And Ratios for Xponential Fitness

Quarterly Metrics And Ratios for Xponential Fitness

Frequently Asked Questions About Xponential Fitness' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools